3OPE | B:2151-2256; B:2151-2256 | STRUCTURAL BASIS OF AUTO-INHIBITORY MECHANISM OF HISTONE METHYLTRANSFERASE |
2RFI | B:1106-1204; B:1106-1204 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN EUCHROMATIC HISTONE METHYLTRANSFERASE 1 IN COMPLEX WITH SAH AND DIMETHYLATED H3K9 PEPTIDE |
3MO0 | B:1106-1204; B:1106-1204 | HUMAN G9A-LIKE (GLP, ALSO KNOWN AS EHMT1) IN COMPLEX WITH INHIBITOR E11 |
3MO2 | D:1106-1204; D:1106-1204; D:1106-1204; D:1106-1204 | HUMAN G9A-LIKE (GLP, ALSO KNOWN AS EHMT1) IN COMPLEX WITH INHIBITOR E67 |
3MO5 | D:1106-1204; D:1106-1204; D:1106-1204; D:1106-1204 | HUMAN G9A-LIKE (GLP, ALSO KNOWN AS EHMT1) IN COMPLEX WITH INHIBITOR E72 |
2O8J | D:1049-1155; D:1049-1155; D:1049-1155; D:1049-1155 | HUMAN EUCHROMATIC HISTONE METHYLTRANSFERASE 2 |
3K5K | B:1049-1155; B:1049-1155 | DISCOVERY OF A 2,4-DIAMINO-7-AMINOALKOXY-QUINAZOLINE AS A POTENT INHIBITOR OF HISTONE LYSINE METHYLTRANSFERASE, G9A |
3RJW | B:1049-1155; B:1049-1155 | CRYSTAL STRUCTURE OF HISTONE LYSINE METHYLTRANSFERASE G9A WITH AN INHIBITOR |
3OOI | A:102-208 | CRYSTAL STRUCTURE OF HUMAN HISTONE-LYSINE N-METHYLTRANSFERASE NSD1 SET DOMAIN IN COMPLEX WITH S-ADENOSYL-L-METHIONINE |
2JV0 | A:42-141 | SET DOMAIN OF RIZ1 TUMOR SUPPRESSOR (PRDM2) |
2QPW | A:41-140 | METHYLTRANSFERASE DOMAIN OF HUMAN PR DOMAIN-CONTAINING PROTEIN 2 |
3QXY | B:74-286; B:74-286 | HUMAN SETD6 IN COMPLEX WITH RELA LYS310 |
3RC0 | B:74-286; B:74-286 | HUMAN SETD6 IN COMPLEX WITH RELA LYS310 PEPTIDE |
1MT6 | A:227-336 | STRUCTURE OF HISTONE H3 K4-SPECIFIC METHYLTRANSFERASE SET7/9 WITH ADOHCY |
1MUF | A:227-336 | STRUCTURE OF HISTONE H3 K4-SPECIFIC METHYLTRANSFERASE SET7/9 |
1N6A | A:227-336 | STRUCTURE OF SET7/9 |
1N6C | A:227-336 | STRUCTURE OF SET7/9 |
1O9S | B:227-336; B:227-336 | CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE METHYLTRANSFERASE SET7/9 |
1XQH | E:227-336; E:227-336 | CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE METHYLTRANSFERASE SET9 (ALSO KNOWN AS SET7/9) WITH A P53 PEPTIDE AND SAH |
3M53 | A:227-336 | SET7/9 IN COMPLEX WITH TAF10 PEPTIDE AND ADOHCY |
3M54 | A:227-336 | SET7/9 Y305F IN COMPLEX WITH TAF10 PEPTIDE AND ADOHCY |
3M55 | A:227-336 | SET7/9 Y305F IN COMPLEX WITH TAF10-K189ME1 PEPTIDE AND ADOHCY |
3M56 | A:227-336 | SET7/9 Y305F IN COMPLEX WITH TAF10-K189ME2 PEPTIDE AND ADOHCY |
3M58 | A:227-336 | SET7/9 Y245A IN COMPLEX WITH TAF10-K189ME1 PEPTIDE AND ADOHCY |
3M59 | A:227-336 | SET7/9 Y245A IN COMPLEX WITH TAF10-K189ME2 PEPTIDE AND ADOHCY |
3M5A | A:227-336 | SET7/9 Y245A IN COMPLEX WITH TAF10-K189ME3 PEPTIDE AND ADOHCY |
3OS5 | A:227-336 | SET7/9-DNMT1 K142ME1 COMPLEX |
3OXF | B:15-240; B:15-240 | HUMAN LYSINE METHYLTRANSFERASE SMYD3 IN COMPLEX WITH ADOHCY (FORM I) |
3OXG | A:15-240 | HUMAN LYSINE METHYLTRANSFERASE SMYD3 IN COMPLEX WITH ADOHCY (FORM III) |
3OXL | A:15-240 | HUMAN LYSINE METHYLTRANSFERASE SMYD3 IN COMPLEX WITH ADOHCY (FORM II) |
3PDN | A:15-240 | CRYSTAL STRUCTURE OF SMYD3 IN COMPLEX WITH METHYLTRANSFERASE INHIBITOR SINEFUNGIN |
3QWP | A:15-240 | CRYSTAL STRUCTURE OF SET AND MYND DOMAIN CONTAINING 3; ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 1 |
3RU0 | B:15-240; B:15-240 | COCRYSTAL STRUCTURE OF HUMAN SMYD3 WITH INHIBITOR SINEFUNGIN BOUND |
2R3A | A:151-262 | METHYLTRANSFERASE DOMAIN OF HUMAN SUPPRESSOR OF VARIEGATION 3-9 HOMOLOG 2 |